{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01280149",
      "orgStudyIdInfo": {
        "id": "BB-IND 4458"
      },
      "organization": {
        "fullName": "Northwestern University",
        "class": "OTHER"
      },
      "briefTitle": "Reduction of IgE Antibody in Human Allergic Subjects",
      "officialTitle": "Reduction of IgE Antibody in Human Allergic Subjects"
    },
    "statusModule": {
      "statusVerifiedDate": "2018-08",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2011-01"
      },
      "primaryCompletionDateStruct": {
        "date": "2017-06-20",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2017-06-20",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2011-01-18",
      "studyFirstSubmitQcDate": "2011-01-18",
      "studyFirstPostDateStruct": {
        "date": "2011-01-20",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2018-08-20",
      "lastUpdatePostDateStruct": {
        "date": "2018-08-21",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Paul Greenberger",
        "investigatorTitle": "Professor of Medicine",
        "investigatorAffiliation": "Northwestern University"
      },
      "leadSponsor": {
        "name": "Northwestern University",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "The purpose of this study is to determine whether a neuropeptide, substance P, when injected along with an allergen, such as ragweed, can reduce allergic reactivity.",
      "detailedDescription": "Allergic Rhinitis (Hay fever) affects many children and adults and is a risk factor for development of asthma. This study utilizes the neurotransmitter, substance P, a small molecule which is present in nerve endings, the brain, skin, lungs and the gastrointestinal tract. Subjects will receive substance P and a low dosage of an allergen, such as ragweed in an attempt to reduce allergic reactivity."
    },
    "conditionsModule": {
      "conditions": [
        "Seasonal Allergic Rhinitis"
      ],
      "keywords": [
        "substance P",
        "allergic rhinitis",
        "allergen immunotherapy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "SINGLE",
          "whoMasked": [
            "PARTICIPANT"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 40,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "substance P-low dose allergen",
          "type": "EXPERIMENTAL",
          "description": "Substance P injections with 8 sequential, increasing doses of allergen",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        },
        {
          "label": "substance P-moderate dose allergen",
          "type": "EXPERIMENTAL",
          "description": "Substance P with sequential, increasing doses of allergen",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        },
        {
          "label": "substance P-low/moderate dose allergen",
          "type": "EXPERIMENTAL",
          "description": "substance P with 16 sequential increasing doses of allergen",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        },
        {
          "label": "substance P-placebo",
          "type": "ACTIVE_COMPARATOR",
          "description": "Placebo injections of substance P and placebo",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        },
        {
          "label": "placebo-low dose allergen",
          "type": "EXPERIMENTAL",
          "description": "Placebo injections with 8 sequential increasing low dose allergen injections",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        },
        {
          "label": "placebo-placebo",
          "type": "PLACEBO_COMPARATOR",
          "description": "substance P placebo and allergen placebo (weekly)",
          "interventionNames": [
            "Biological: substance P",
            "Biological: substance P injections"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "substance P",
          "description": "injections of substance P and low dose allergen or placebo",
          "armGroupLabels": [
            "placebo-low dose allergen",
            "placebo-placebo",
            "substance P-low dose allergen",
            "substance P-low/moderate dose allergen",
            "substance P-moderate dose allergen",
            "substance P-placebo"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "substance P injections",
          "description": "injections of substance P for 8 weeks",
          "armGroupLabels": [
            "placebo-low dose allergen",
            "placebo-placebo",
            "substance P-low dose allergen",
            "substance P-low/moderate dose allergen",
            "substance P-moderate dose allergen",
            "substance P-placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "CBER ID50 skin test result",
          "description": "The ID50 skin test result utilizes FDA CBER methodology to determine the change in allergic skin reactivity to ragweed and grass pollen allergens.",
          "timeFrame": "1 to 6 months after completing injections"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* positive immediate type skin test to ragweed or grass pollen or a third (standardized) allergen if both ragweed and grass pollen allergen are not positive\n* volunteers should be available for allergen injections and then cutaneous titrations for approximately 1 year from the start of the enrollment period\n\nExclusion Criteria:\n\n* volunteer is pregnant or lactating\n* abnormal electrocardiogram for subjects over 50 years of age\n* use of beta adrenergic antagonists or tricyclic antidepressants",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "65 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Paul A Greenberger, M.D.",
          "affiliation": "Northwestern University Feinberg School of Medicine",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Northwestern University Feinberg School of Medicine",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60611",
          "country": "United States",
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006255",
          "term": "Rhinitis, Allergic, Seasonal"
        },
        {
          "id": "D065631",
          "term": "Rhinitis, Allergic"
        }
      ],
      "ancestors": [
        {
          "id": "D012220",
          "term": "Rhinitis"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D013373",
          "term": "Substance P"
        }
      ],
      "ancestors": [
        {
          "id": "D015320",
          "term": "Tachykinins"
        },
        {
          "id": "D007705",
          "term": "Kinins"
        },
        {
          "id": "D036341",
          "term": "Intercellular Signaling Peptides and Proteins"
        },
        {
          "id": "D010455",
          "term": "Peptides"
        },
        {
          "id": "D000602",
          "term": "Amino Acids, Peptides, and Proteins"
        },
        {
          "id": "D009479",
          "term": "Neuropeptides"
        },
        {
          "id": "D009842",
          "term": "Oligopeptides"
        },
        {
          "id": "D011506",
          "term": "Proteins"
        },
        {
          "id": "D009419",
          "term": "Nerve Tissue Proteins"
        },
        {
          "id": "D012898",
          "term": "Autacoids"
        },
        {
          "id": "D018836",
          "term": "Inflammation Mediators"
        },
        {
          "id": "D001685",
          "term": "Biological Factors"
        }
      ]
    }
  },
  "hasResults": false
}